RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

Clinical trials for RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) explained in plain language.

Never miss a new study

Get alerted when new RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) trials appear

Sign up with your email to follow new studies for RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug tested on kids with Tough-to-Treat leukemia

Disease control Ongoing

This early-stage study is testing a new drug called KPT-330 in children and young adults whose leukemia has returned or stopped responding to standard treatments. The main goal is to find the highest safe dose and understand the side effects. Researchers will give different dose …

Matched conditions: RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control

Last updated Apr 02, 2026 12:12 UTC

RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

Get alerted when new RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) trials appear

New drug tested on kids with Tough-to-Treat leukemia